Report Detail
Global Incretin-Based Drugs Market Professional Survey Report 2019
- RnM3808982 |
- 09 October, 2019 |
- Global |
- 102 Pages |
- QYResearch |
- Pharma & Healthcare
Incretins are gut derived hormones, released after the ingestion of food. Incretins are classified into glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Both the molecules are inactivated by enzyme Dipeptidyl Peptidase-4 (DPP-4).
Oral traditional anti-diabetic drugs, often fail to maintain the desired normal level of glucose, especially in the postprandial condition.
This has resulted in a strong need for better therapeutics such as incretin based drugs.
Incretin not only increases the secretion of insulin by acting on pancreatic beta cells, but also inhibits the release of glucagon by acting on the pancreatic alpha cells.
The global Incretin-Based Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Incretin-Based Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Incretin-Based Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Incretin-Based Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Incretin-Based Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
GlaxoSmithKline
Johnson & Johnson
Merck & Co
AstraZeneca
Novartis
Eli Lilly and Company
Boehringer Ingelheim
Takeda Pharmaceutical Company
Sanofi
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Glucagon-like peptide-1 receptor (GLP-1) agonists
Dipeptidyl Peptidase-4 (DPP-4) inhibitors
Segment by Application
Oral Drugs
Injectable Drugs
Table of Contents
Executive Summary
1 Industry Overview of Incretin-Based Drugs
- 1.1 Definition of Incretin-Based Drugs
- 1.2 Incretin-Based Drugs Segment by Type
- 1.2.1 Global Incretin-Based Drugs Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Glucagon-like peptide-1 receptor (GLP-1) agonists
- 1.2.3 Dipeptidyl Peptidase-4 (DPP-4) inhibitors
- 1.3 Incretin-Based Drugs Segment by Applications
- 1.3.1 Global Incretin-Based Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Oral Drugs
- 1.3.3 Injectable Drugs
- 1.4 Global Incretin-Based Drugs Overall Market
- 1.4.1 Global Incretin-Based Drugs Revenue (2014-2025)
- 1.4.2 Global Incretin-Based Drugs Production (2014-2025)
- 1.4.3 North America Incretin-Based Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe Incretin-Based Drugs Status and Prospect (2014-2025)
- 1.4.5 China Incretin-Based Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan Incretin-Based Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Incretin-Based Drugs Status and Prospect (2014-2025)
- 1.4.8 India Incretin-Based Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Incretin-Based Drugs
- 2.3 Manufacturing Process Analysis of Incretin-Based Drugs
- 2.4 Industry Chain Structure of Incretin-Based Drugs
3 Development and Manufacturing Plants Analysis of Incretin-Based Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Incretin-Based Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Incretin-Based Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Incretin-Based Drugs Production and Capacity Analysis
- 4.2 Incretin-Based Drugs Revenue Analysis
- 4.3 Incretin-Based Drugs Price Analysis
- 4.4 Market Concentration Degree
5 Incretin-Based Drugs Regional Market Analysis
- 5.1 Incretin-Based Drugs Production by Regions
- 5.1.1 Global Incretin-Based Drugs Production by Regions
- 5.1.2 Global Incretin-Based Drugs Revenue by Regions
- 5.2 Incretin-Based Drugs Consumption by Regions
- 5.3 North America Incretin-Based Drugs Market Analysis
- 5.3.1 North America Incretin-Based Drugs Production
- 5.3.2 North America Incretin-Based Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Incretin-Based Drugs Import and Export
- 5.4 Europe Incretin-Based Drugs Market Analysis
- 5.4.1 Europe Incretin-Based Drugs Production
- 5.4.2 Europe Incretin-Based Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Incretin-Based Drugs Import and Export
- 5.5 China Incretin-Based Drugs Market Analysis
- 5.5.1 China Incretin-Based Drugs Production
- 5.5.2 China Incretin-Based Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Incretin-Based Drugs Import and Export
- 5.6 Japan Incretin-Based Drugs Market Analysis
- 5.6.1 Japan Incretin-Based Drugs Production
- 5.6.2 Japan Incretin-Based Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Incretin-Based Drugs Import and Export
- 5.7 Southeast Asia Incretin-Based Drugs Market Analysis
- 5.7.1 Southeast Asia Incretin-Based Drugs Production
- 5.7.2 Southeast Asia Incretin-Based Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Incretin-Based Drugs Import and Export
- 5.8 India Incretin-Based Drugs Market Analysis
- 5.8.1 India Incretin-Based Drugs Production
- 5.8.2 India Incretin-Based Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Incretin-Based Drugs Import and Export
6 Incretin-Based Drugs Segment Market Analysis (by Type)
- 6.1 Global Incretin-Based Drugs Production by Type
- 6.2 Global Incretin-Based Drugs Revenue by Type
- 6.3 Incretin-Based Drugs Price by Type
7 Incretin-Based Drugs Segment Market Analysis (by Application)
- 7.1 Global Incretin-Based Drugs Consumption by Application
- 7.2 Global Incretin-Based Drugs Consumption Market Share by Application (2014-2019)
8 Incretin-Based Drugs Major Manufacturers Analysis
- 8.1 GlaxoSmithKline
- 8.1.1 GlaxoSmithKline Incretin-Based Drugs Production Sites and Area Served
- 8.1.2 GlaxoSmithKline Product Introduction, Application and Specification
- 8.1.3 GlaxoSmithKline Incretin-Based Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Johnson & Johnson
- 8.2.1 Johnson & Johnson Incretin-Based Drugs Production Sites and Area Served
- 8.2.2 Johnson & Johnson Product Introduction, Application and Specification
- 8.2.3 Johnson & Johnson Incretin-Based Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Merck & Co
- 8.3.1 Merck & Co Incretin-Based Drugs Production Sites and Area Served
- 8.3.2 Merck & Co Product Introduction, Application and Specification
- 8.3.3 Merck & Co Incretin-Based Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 AstraZeneca
- 8.4.1 AstraZeneca Incretin-Based Drugs Production Sites and Area Served
- 8.4.2 AstraZeneca Product Introduction, Application and Specification
- 8.4.3 AstraZeneca Incretin-Based Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Novartis
- 8.5.1 Novartis Incretin-Based Drugs Production Sites and Area Served
- 8.5.2 Novartis Product Introduction, Application and Specification
- 8.5.3 Novartis Incretin-Based Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Eli Lilly and Company
- 8.6.1 Eli Lilly and Company Incretin-Based Drugs Production Sites and Area Served
- 8.6.2 Eli Lilly and Company Product Introduction, Application and Specification
- 8.6.3 Eli Lilly and Company Incretin-Based Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Boehringer Ingelheim
- 8.7.1 Boehringer Ingelheim Incretin-Based Drugs Production Sites and Area Served
- 8.7.2 Boehringer Ingelheim Product Introduction, Application and Specification
- 8.7.3 Boehringer Ingelheim Incretin-Based Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Takeda Pharmaceutical Company
- 8.8.1 Takeda Pharmaceutical Company Incretin-Based Drugs Production Sites and Area Served
- 8.8.2 Takeda Pharmaceutical Company Product Introduction, Application and Specification
- 8.8.3 Takeda Pharmaceutical Company Incretin-Based Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Sanofi
- 8.9.1 Sanofi Incretin-Based Drugs Production Sites and Area Served
- 8.9.2 Sanofi Product Introduction, Application and Specification
- 8.9.3 Sanofi Incretin-Based Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Incretin-Based Drugs Market
- 9.1 Global Incretin-Based Drugs Market Trend Analysis
- 9.1.1 Global Incretin-Based Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Incretin-Based Drugs Regional Market Trend
- 9.2.1 North America Incretin-Based Drugs Forecast 2019-2025
- 9.2.2 Europe Incretin-Based Drugs Forecast 2019-2025
- 9.2.3 China Incretin-Based Drugs Forecast 2019-2025
- 9.2.4 Japan Incretin-Based Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia Incretin-Based Drugs Forecast 2019-2025
- 9.2.6 India Incretin-Based Drugs Forecast 2019-2025
- 9.3 Incretin-Based Drugs Market Trend (Product Type)
- 9.4 Incretin-Based Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Incretin-Based Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Incretin-Based Drugs. Industry analysis & Market Report on Incretin-Based Drugs is a syndicated market report, published as Global Incretin-Based Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Incretin-Based Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
